Reduced Baseline Sensitivity to Maraviroc Inhibition Among R5 HIV-1 Isolates From Individuals With Severe Immunodeficiency

被引：2
作者：
Karlsson, Ulf [1 ]
Repits, Johanna [2 ]
Antonsson, Liselotte [3 ]
Cederfjall, Erik [3 ]
Ljungberg, Bengt [1 ]
Alenius, Martin [1 ]
Sabirsh, Alan [4 ]
Gisslen, Magnus [5 ]
Esbjoernsson, Joakim [6 ]
Jansson, Marianne [2 ,7 ]
机构：
[1] Lund Univ, Dept Clin Sci, Lund, Sweden
[2] Lund Univ, Dept Lab Med, Lund, Sweden
[3] Lund Univ, Dept Expt Med Sci, Lund, Sweden
[4] AstraZeneca R&D, Dept Neurosci CNS & Pain, Sodertalje, Sweden
[5] Univ Gothenburg, Dept Infect Dis, Gothenburg, Sweden
[6] Univ Oxford, Nuffield Dept Med, Oxford, England
[7] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2016年 / 71卷 / 03期
关键词：
MOLECULE CCR5 INHIBITORS; VIRUS TYPE-1; RANTES SENSITIVITY; CORECEPTOR USAGE; ENTRY INHIBITOR; STAGE DISEASE; RESISTANCE; RECEPTOR; VARIANTS; GP120;
D O I：
10.1097/QAI.0000000000000873
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Supplemental Digital Content is Available in the Text.
引用
收藏
页码：E79 / E82
页数：4
相关论文
共 36 条
  • [1] Resistance to CCR5 inhibitors caused by sequence changes in the fusion peptide of HIV-1 gp41
    Anastassopoulou, Cleo G.
    Ketas, Thomas J.
    Klasse, Per Johan
    Moore, John P.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (13) : 5318 - 5323
  • [2] Different selection patterns of resistance and cross-resistance to HIV-1 agents targeting CCR5
    Armand-Ugon, Mercedes
    Moncunill, Gemma
    Gonzalez, Emmanuel
    Mena, MariaPau
    Ballana, Ester
    Clotet, Bonaventura
    Este, Jose A.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (03) : 417 - 424
  • [3] Isolation and characterization of human immunodeficiency virus type 1 resistant to the small-molecule CCR5 antagonist TAK-652
    Baba, Masanori
    Miyake, Hiroshi
    Wang, Xin
    Okamoto, Mika
    Takashima, Katsunori
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (02) : 707 - 715
  • [4] Two HIV-1 Variants Resistant to Small Molecule CCR5 Inhibitors Differ in How They Use CCR5 for Entry
    Berro, Reem
    Sanders, Rogier W.
    Lu, Min
    Klasse, Per J.
    Moore, John P.
    [J]. PLOS PATHOGENS, 2009, 5 (08)
  • [5] Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-I variants emerging during AIDS progression
    Borggren, Marie
    Repits, Johanna
    Kuylenstierna, Carlotta
    Sterjovski, Jasminka
    Churchill, Melissa J.
    Purcell, Damian F. J.
    Karlsson, Anders
    Albert, Jan
    Gorry, Paul R.
    Jansson, Marianne
    [J]. RETROVIROLOGY, 2008, 5 (1)
  • [6] Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity
    Dorr, P
    Westby, M
    Dobbs, S
    Griffin, P
    Irvine, B
    Macartney, M
    Mori, J
    Rickett, G
    Smith-Burchnell, C
    Napier, C
    Webster, R
    Armour, D
    Price, D
    Stammen, B
    Wood, A
    Perros, M
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (11) : 4721 - 4732
  • [7] Frequent CXCR4 tropism of HIV-1 subtype A and CRF02_AG during late-stage disease - indication of an evolving epidemic in West Africa
    Esbjornsson, Joakim
    Mansson, Fredrik
    Martinez-Arias, Wilma
    Vincic, Elzbieta
    Biague, Antonio J.
    da Silva, Zacarias J.
    Fenyo, Eva Maria
    Norrgren, Hans
    Medstrand, Patrik
    [J]. RETROVIROLOGY, 2010, 7
  • [8] Human immunodeficiency virus type 1 biological variation and coreceptor use: from concept to clinical significance
    Fenyo, E. M.
    Esbjornsson, J.
    Medstrand, P.
    Jansson, M.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2011, 270 (06) : 520 - 531
  • [9] Geipel A, 2015, ANTIVIR THER
  • [10] Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome
    Gray, L
    Sterjovski, J
    Churchill, M
    Ellery, P
    Nasr, N
    Lewin, SR
    Crowe, SM
    Wesselingh, SL
    Cunningham, AL
    Gorry, PR
    [J]. VIROLOGY, 2005, 337 (02) : 384 - 398
1234